Safety and tolerance of rapidly infused Depacon®: A randomized trial in subjects with epilepsy
- 31 January 2003
- journal article
- clinical trial
- Published by Elsevier BV in Epilepsy Research
- Vol. 52 (3), 189-201
- https://doi.org/10.1016/s0920-1211(02)00187-0
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Intravenous valproate is well tolerated in unstable patients with status epilepticusNeurology, 2000
- Intravenous Loading of Valproate for EpilepsyClinical Neuropharmacology, 1999
- Tiagabine Therapy for Complex Partial SeizuresArchives of Neurology, 1997
- Safety and Efficacy of Divalproex Sodium Monotherapy in Partial EpilepsyNeurology, 1997
- Pharmacokinetics of Valproate After Multiple-Dose Oral and Intravenous Infusion Administration: Gastrointestinal-Related Diurnal VariationThe Journal of Clinical Pharmacology, 1994
- Pharmacokinetics of Multiple Oral Dose Divalproex Sodium after Intravenous Loading Dose Administration in Healthy VolunteersClinical Drug Investigation, 1994
- Effect of infusion duration on valproate pharmacokineticsBiopharmaceutics & Drug Disposition, 1993
- Intravenous valproate: onset and duration of anticonvulsant activity against a series of electroconvulsions in comparison with diazepam and phenytoinEpilepsy Research, 1992
- Comparison of Carbamazepine, Phenobarbital, Phenytoin, and Primidone in Partial and Secondarily Generalized Tonic–Clonic SeizuresThe New England Journal of Medicine, 1985
- PHARMACOKINETICS OF VALPROIC ACID AFTER ORAL AND INTRAVENOUS ADMINISTRATIONBritish Journal of Clinical Pharmacology, 1978